These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 20819888)

  • 41. The value equation for rosiglitazone and pioglitazone in older persons.
    Zarowitz BJ
    Geriatr Nurs; 2008; 29(1):9-11. PubMed ID: 18267172
    [No Abstract]   [Full Text] [Related]  

  • 42. Rosiglitazone and implications for pharmacovigilance.
    Kazi D
    BMJ; 2007 Jun; 334(7606):1233-4. PubMed ID: 17569897
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Is the FDA on drugs?
    Calabresi M; Park A
    Time; 2010 Aug; 176(8):24-8. PubMed ID: 20821962
    [No Abstract]   [Full Text] [Related]  

  • 44. [Pioglitazone in evaluation by IQWiG (Institute for Quality and Cost Effectiveness in Public Health)--tunnel vision instead of broad view].
    MMW Fortschr Med; 2008 Aug; 150(32-35):56-7. PubMed ID: 19009700
    [No Abstract]   [Full Text] [Related]  

  • 45. Responding to an FDA warning--geographic variation in the use of rosiglitazone.
    Shah ND; Montori VM; Krumholz HM; Tu K; Alexander GC; Jackevicius CA
    N Engl J Med; 2010 Nov; 363(22):2081-4. PubMed ID: 21083379
    [No Abstract]   [Full Text] [Related]  

  • 46. The record on rosiglitazone and the risk of myocardial infarction.
    Psaty BM; Furberg CD
    N Engl J Med; 2007 Jul; 357(1):67-9. PubMed ID: 17551162
    [No Abstract]   [Full Text] [Related]  

  • 47. [Rosiglitazone].
    Johansen K
    Ugeskr Laeger; 2010 Sep; 172(38):2631; author reply 2631. PubMed ID: 20931733
    [No Abstract]   [Full Text] [Related]  

  • 48. [Glitazone - mailing no 1. In response to DMW 49/2007].
    Traut V
    Dtsch Med Wochenschr; 2008 Feb; 133(6):261; author reply 262-3. PubMed ID: 18236356
    [No Abstract]   [Full Text] [Related]  

  • 49. [Glitazone - mailing no 3. In response to DMW 49/2007].
    Gundel UF
    Dtsch Med Wochenschr; 2008 Feb; 133(6):261-2; author reply 262-3. PubMed ID: 18236354
    [No Abstract]   [Full Text] [Related]  

  • 50. Rosiglitazone and the FDA.
    Krall RL
    N Engl J Med; 2007 Oct; 357(17):1776-7; author reply 1777. PubMed ID: 17969232
    [No Abstract]   [Full Text] [Related]  

  • 51. The long Avandia endgame.
    Mullard A
    Lancet; 2011 Jul; 378(9786):113. PubMed ID: 21748869
    [No Abstract]   [Full Text] [Related]  

  • 52. After Avandia, some seek split in drug approval and monitoring.
    Dolgin E
    Nat Med; 2010 Aug; 16(8):831. PubMed ID: 20689527
    [No Abstract]   [Full Text] [Related]  

  • 53. Cardiovascular effects of thiazolidinediones: a review of the literature.
    Acharya D; Falik R
    South Med J; 2009 Jan; 102(1):51-6. PubMed ID: 19077768
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diabetes drugs offered fresh start.
    Ledford H
    Nature; 2010 Jul; 466(7305):420-1. PubMed ID: 20651662
    [No Abstract]   [Full Text] [Related]  

  • 55. Faster publication isn't always better.
    Fuster V; Farkouh ME
    Nat Clin Pract Cardiovasc Med; 2007 Jul; 4(7):345. PubMed ID: 17589426
    [No Abstract]   [Full Text] [Related]  

  • 56. Australian government tries to stop independent advice on diabetes drugs.
    Burton B
    BMJ; 2003 Dec; 327(7428):1368. PubMed ID: 14670876
    [No Abstract]   [Full Text] [Related]  

  • 57. The balance of benefit and safety of rosiglitazone: important lessons for our system of drug development and postmarketing assessment.
    Califf RM; Kramer JM
    Pharmacoepidemiol Drug Saf; 2008 Aug; 17(8):782-6. PubMed ID: 18655016
    [No Abstract]   [Full Text] [Related]  

  • 58. Assessing the Safety of Glucose-Lowering Drugs - A New Focus for the FDA.
    Chong WH; Yanoff LB; Andraca-Carrera E; Thanh Hai M
    N Engl J Med; 2020 Sep; 383(13):1199-1202. PubMed ID: 32966719
    [No Abstract]   [Full Text] [Related]  

  • 59. Rosiglitazone and cardiovascular disease: a diabetologist's perspective.
    Grant PJ
    Diab Vasc Dis Res; 2007 Jun; 4(2):75-6. PubMed ID: 17654437
    [No Abstract]   [Full Text] [Related]  

  • 60. Is rosiglitazone as safe as BARI 2D and the reanalysis of RECORD imply?
    DiNicolantonio JJ; Meier P
    Cardiology; 2014; 127(3):152-4. PubMed ID: 24335113
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.